TIL Therapy for Metastatic Renal Cell Carcinoma

Clinical trial NCT02926053 · COMPLETED

Trial details

NCT number: NCT02926053
Sponsor: Inge Marie Svane
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2016-12-01
Primary completion: 2021-10-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.